Description

N2-[N2-(3-Hydroxy-9-Methyl-1-Oxodecyl)-D-Dab-]Cyclo[L-Dab*-L-Dab-D-Leu-L-Phe-L-Dab-L-Dab-L-Leu-] is a complex, synthetic cyclic peptide derivative, also known as a lipopeptide antibiotic precursor. This compound is of significant interest in advanced pharmaceutical research and development due to its intricate structure, which is designed to mimic or interfere with natural biological processes. It serves as a critical intermediate or reference standard for the synthesis and study of novel antimicrobial agents, particularly those targeting resistant bacterial strains. Key industries that require this high-purity specialty chemical include pharmaceutical R&D, biotechnology, and academic research institutions focused on developing next-generation therapeutics.

Application

• Pharmaceutical Intermediate: Serves as a key building block in the synthesis of novel lipopeptide antibiotics and other peptide-based therapeutic agents.
• Research & Development: Used as a reference standard or lead compound in biochemical and microbiological research to study structure-activity relationships (SAR) and mechanism of action.
• Antimicrobial Agent Development: Investigated for its potential activity against drug-resistant bacteria, including Gram-positive pathogens like MRSA (Methicillin-resistant *Staphylococcus aureus*).
• Bioconjugation Studies: Utilized in the development of targeted drug delivery systems due to its peptide backbone and functional groups suitable for conjugation.
• Academic Research: Employed in university and institutional labs for advanced studies in medicinal chemistry, peptide synthesis, and antibiotic discovery.
• Quality Control & Analytical Standards: Acts as a high-purity certified reference material (CRM) for analytical method development and validation in QC laboratories.

Basic Information

Item	Detail
Product Name	N2-[N2-(3-Hydroxy-9-Methyl-1-Oxodecyl)-D-Dab-]Cyclo[L-Dab*-L-Dab-D-Leu-L-Phe-L-Dab-L-Dab-L-Leu-]
CAS No.	71043-99-7
Molecular Formula	C58H98N12O12
Molecular Weight	1131.5 g/mol
Synonyms	Cyclic Lipopeptide Antibiotic Intermediate; [D-Dab1, L-Dab2, L-Dab5, L-Dab6, D-Leu3, L-Phe4, L-Leu7]cyclo-peptide derivative; 3-Hydroxy-9-methyl-1-oxodecyl-D-Dab-cyclo(L-Dab-L-Dab-D-Leu-L-Phe-L-Dab-L-Dab-L-Leu); Lipopeptide precursor 71043-99-7; Antibiotic core structure; Synthetic cyclic peptide; Contact for additional synonyms.
EINECS	Contact for details

Quality Control

Our production of N2-[N2-(3-Hydroxy-9-Methyl-1-Oxodecyl)-D-Dab-]Cyclo[L-Dab*-L-Dab-D-Leu-L-Phe-L-Dab-L-Dab-L-Leu-] adheres to stringent quality management protocols suitable for research and pharmaceutical-grade materials. Each batch undergoes comprehensive analytical testing, including HPLC for purity, mass spectrometry (MS) for identity confirmation, and NMR for structural verification. We provide a detailed Certificate of Analysis (COA) with every shipment, ensuring traceability and compliance with your internal quality standards. Our commitment is to supply high-purity, well-characterized reference materials to support critical R&D and preclinical studies.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below for long-term stability. This compound is hygroscopic (moisture-sensitive); ensure the container is sealed under an inert atmosphere (e.g., nitrogen or argon) after each use to prevent degradation. For short-term use, the material may be kept at 2-8°C. Allow the sealed vial to equilibrate to room temperature before opening to minimize moisture condensation.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC-MS)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 95.0%
Water Content (KF)	≤ 2.0%
Residual Solvents (GC)	Meets ICH guidelines
Specific Rotation	Contact for details

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.